Tenable Holdings Inc
For the period ended Mar 31, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
10. Stock-Based Compensation
- Stock-Based Compensation
Stock-based compensation expense included in the consolidated statements of operations was as follows:
| Three Months Ended March 31, | ||
|---|---|---|
| (in thousands) | 2025 | 2024 |
| Cost of revenue | $3,315 | $2,982 |
| Sales and marketing | 16,630 | 15,300 |
| Research and development | 12,967 | 11,161 |
| General and administrative(1) | 22,991 | 10,276 |
| Total stock-based compensation expense | $55,903 | $39,719 |
(1)Stock-based compensation in the three months ended March 31, 2025 includes $14.6 million of expense related to the accelerated vesting of equity awards for our late CEO.
A summary of the unrecognized stock-based compensation expense related to unvested stock at March 31, 2025 is presented below:
| Unrecognized Stock-Based Compensation Expense (in thousands) | Estimated Weighted Average Period (in years) | |
|---|---|---|
| Restricted stock units ("RSUs") | $390,014 | 3.0 |
| Performance stock units ("PSUs") | 9,502 | 3.6 |
| Restricted stock | 5,716 | 1.0 |
| 2018 Employee Stock Purchase Plan ("2018 ESPP") | 14,412 | 1.0 |
Restricted Stock, RSUs and PSUs
A summary of our restricted stock, RSU and PSU activity is presented below:
| Restricted Stock | RSUs | PSUs | ||||
|---|---|---|---|---|---|---|
| (in thousands, except for per share data) | Number of Shares | WeightedAverageGrant Date Fair Value | Number of Shares | WeightedAverageGrant Date Fair Value | Number of Shares | WeightedAverageGrant Date Fair Value |
| Unvested balance at December 31, 2024 | 187 | $45.67 | 7,209 | $45.01 | 300 | $45.78 |
| Granted | — | — | 4,502 | 38.52 | 200 | 38.37 |
| Performance adjustment(1) | — | — | — | — | (6) | 47.20 |
| Vested | (31) | 45.67 | (1,599) | 45.91 | (163) | 46.12 |
| Forfeited | — | — | (187) | 44.99 | — | — |
| Unvested balance at March 31, 2025 | 156 | 45.67 | 9,925 | 41.93 | 331 | 41.10 |
(1) Represents adjustments due to the achievement of predefined financial performance targets.
In January 2025, under the evergreen provision in our 2018 Equity Incentive Plan we reserved an additional 6.0 million shares of our common stock. At March 31, 2025, there were 27.5 million shares available for grant under the plan.
Stock Options
A summary of our stock option activity is presented below:
| (in thousands, except for exercise prices and years) | Numberof Shares | WeightedAverageExercise Price | Weighted-Average Remaining Contractual Term (in years) | Aggregate Intrinsic Value |
|---|---|---|---|---|
| Outstanding at December 31, 2024 | 4,051 | $9.26 | 2.6 | $122,024 |
| Exercised | (52) | 6.72 | 1,654 | |
| Forfeited/canceled | — | — | — | |
| Outstanding and exercisable at March 31, 2025 | 3,999 | 9.29 | 1.6 | 102,739 |
2018 Employee Stock Purchase Plan
In the three months ended March 31, 2025, employees purchased 0.3 million shares of our common stock at a weighted average price of $32.42 per share, resulting in $9.7 million of cash proceeds. At March 31, 2025, there was $1.5 million of employee contributions to the 2018 ESPP included in accrued compensation.
The fair value of the 2018 ESPP purchase rights was estimated on the offering or modification dates using a Black-Scholes option-pricing model and the following assumptions:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Expected term (in years) | 0.5 — 2.0 | 0.5 — 2.0 |
| Expected volatility | 30.6% — 38.2% | 41.1% — 51.4% |
| Risk-free interest rate | 3.9% — 4.2% | 4.4% — 5.1% |
| Expected dividend yield | — | — |
Under the evergreen provision in our 2018 ESPP, in January 2025 we reserved an additional 1.8 million shares of our common stock. At March 31, 2025, there were 11.5 million shares reserved for issuance under our 2018 ESPP.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.